Physiological Mechanisms of Cognition and Diabetes Mellitus

Abstract

Diabetes mellitus (DM), a metabolic disorder characterized by hyperglycemia, significantly impacts cognitive function, manifesting as mild cognitive impairment (MCI) or even dementia. This abstract explores the intricate physiological mechanisms underlying this cognitive decline, emphasizing the multifaceted interplay between glucose dysregulation and brain health. Hyperglycemia directly damages neuronal structures and functions through several pathways. Advanced glycation end products (AGEs) accumulate, contributing to oxidative stress, inflammation, and impaired neurotransmission. This oxidative burden reduces cerebral blood flow, leading to neuronal hypoxia and dysfunction in crucial cognitive regions like the hippocampus and prefrontal cortex. Furthermore, chronic hyperglycemia disrupts the blood-brain barrier (BBB) integrity, promoting neuroinflammation and facilitating the entry of harmful molecules into the brain parenchyma. Beyond direct effects, DM affects several neurotransmitter systems critical for cognition. Insulin resistance, often accompanying DM, impairs insulin signaling in the brain, impacting neuronal plasticity, synaptic function, and memory consolidation. Alterations in acetylcholine, glutamate, and other neurotransmitters contribute to cognitive deficits observed in DM. Furthermore, dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, frequently seen in DM, leads to chronic stress and increased cortisol levels, which exacerbate neuronal damage and impair cognitive performance. Vascular complications, a hallmark of DM, further contribute to cognitive decline. Microvascular disease, including cerebral small vessel disease, leads to white matter hyperintensities, reduced cerebral perfusion, and consequent cognitive impairment. Macrovascular complications, such as stroke, directly damage brain tissue, resulting in significant cognitive deficits. The interplay of these micro and macrovascular pathologies underscores the complex relationship between vascular health and cognitive function in DM. Addressing these underlying physiological mechanisms through robust glucose control, lifestyle interventions, and potential novel therapeutic targets is crucial for preventing and managing cognitive decline associated with DM. Future research should focus on identifying early biomarkers and developing targeted interventions to mitigate the cognitive burden of this prevalent metabolic disorder.